US$ 23.68
oral glutathione melasma randomized controlled trial Lack of efficacy of N-acetylcysteine in the treatment of facial in women: a randomized, double-blind, placebo-controlled clinical Systematic Review of the Efficacy
Description
In-situ pre-treatment of vascularized composite allografts with a targeted complement inhibitor protects against brain death and ischemia reperfusion induced injuries

The well-surface functionalized NPs can specifically engage with inflammatory cells in the brain, thus reducing the neuroinflammatory response

After EECGLs intervention, the serum ALT, AST and ALP levels exhibited downward trends compared with those in the HM group

The blots were blocked in 5% (wt/v) blocking buffer
